fingolimod hydrochloride has been researched along with Acute Symptom Flare in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ariño, H; Baños, N; Blanco, Y; Llufriu, S; Martinez-Hernandez, E; Martinez-Lapiscina, EH; Montejo, C; Pulido-Valdeolivas, I; Reyes, D; Saiz, A; Sepúlveda, M; Sola-Valls, N; Zubizarreta, I | 1 |
| Delgado, S; Hernandez, J; Rammohan, K; Tornes, L | 1 |
| Baroncini, D; Boffa, G; Callegari, I; Cellerino, M; Ghezzi, A; Inglese, M; Lapucci, C; Mancardi, GL; Novi, G; Pardini, M; Roccatagliata, L; Sormani, MP; Uccelli, A; Zaffaroni, M | 1 |
3 other study(ies) available for fingolimod hydrochloride and Acute Symptom Flare
| Article | Year |
|---|---|
Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Live Birth; Lymphocytes; Magnetic Resonance Imaging; Multiple Sclerosis; Pregnancy; Pregnancy Complications; Reproductive Behavior; Retrospective Studies; Severity of Illness Index; Symptom Flare Up; Time Factors | 2020 |
Increased multiple sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate: a case series.
Topics: Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dimethyl Fumarate; Drug Substitution; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Symptom Flare Up | 2021 |
Different MRI patterns in MS worsening after stopping fingolimod.
Topics: Adult; Disability Evaluation; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Recurrence; Retrospective Studies; Symptom Flare Up | 2019 |